Overview

A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder

Status:
Terminated
Trial end date:
2020-07-04
Target enrollment:
Participant gender:
Summary
The purpose of this long-term study is to evaluate the safety and efficacy of duloxetine hydrochloride in Japanese children and adolescents with depressive disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Shionogi
Collaborator:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride